TrialHypertension (Dallas, Tex. : 1979)2026

Aprocitentan in Patients With Chronic Kidney Disease and Resistant Hypertension.

Patrick Rossignol et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.